Jenburkt Pharmaceuticals Ltd reports Q2 FY27 revenue of ₹4,831.82 lakh and net profit of ₹1,020.94 lakh
- Revenue rose 6.1% year on year and 36.1% sequentially; net profit increased 0.5% year on year and 73.5% sequentially.
- Operating margin was approximately 26.9%, excluding other income, finance costs and depreciation.
- No exceptional items were reported; the auditor’s limited review conclusion was unmodified.